426
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Modulation of chemotherapy-induced cytotoxicity in SH-SY5Y neuroblastoma cells by caffeine and chlorogenic acid

, , , , , & show all
Pages 363-369 | Received 04 Dec 2016, Accepted 12 Feb 2017, Published online: 06 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (6)

Jamira Dias Rocha, Marilia Elias Gallon, Abel Vieira de Melo Bisneto, Vanessa Cristiane Santana Amaral, Luciane Madureira de Almeida, Leonardo Luiz Borges, Lee Chen-Chen, Leonardo Gobbo-Neto & Elisa Flávia Luiz Cardoso Bailão. (2022) Phytochemical Composition and Protective Effect of Vernonanthura polyanthes Leaf against In Vivo Doxorubicin-Mediated Toxicity. Molecules 27:8, pages 2553.
Crossref
Xiaoli He, Yongkang Liao, Jing Liu & Shuming Sun. (2022) Research Progress of Natural Small-Molecule Compounds Related to Tumor Differentiation. Molecules 27:7, pages 2128.
Crossref
Huanhuan Xu, Litian Wang, Boya Shi, Lihong Hu, Chunxia Gan, Ya Wang, Zemin Xiang, Xuanjun Wang & Jun Sheng. (2020) Caffeine inhibits the anticancer activity of paclitaxel via down-regulation of α-tubulin acetylation. Biomedicine & Pharmacotherapy 129, pages 110441.
Crossref
Miguel Angel Merlos Rodrigo, Hana Buchtelova, Vivian de los Rios, José Ignacio Casal, Tomas Eckschlager, Jan Hrabeta, Marie Belhajova, Zbynek Heger & Vojtech Adam. (2018) Proteomic Signature of Neuroblastoma Cells UKF-NB-4 Reveals Key Role of Lysosomal Sequestration and the Proteasome Complex in Acquiring Chemoresistance to Cisplatin. Journal of Proteome Research 18:3, pages 1255-1263.
Crossref
Ning Li, Pingde Zhang, Karrie Mei Yee Kiang, Yin Stephen Cheng & Gilberto Ka Kit Leung. (2018) Caffeine Sensitizes U87-MG Human Glioblastoma Cells to Temozolomide through Mitotic Catastrophe by Impeding G2 Arrest. BioMed Research International 2018, pages 1-10.
Crossref
. (2017) Selected Literature Watch. Journal of Caffeine Research 7:2, pages 78-79.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.